Horizon Flexible Income ETF (FLXN)

BATS: FLXN · Real-Time Price · USD
25.09
+0.04 (0.15%)
May 8, 2026, 11:15 AM EDT - Market open
Assetsn/a
Expense Ratio0.82%
PE Ration/a
Shares Out1.49M
Dividend (ttm)$1.68
Dividend Yield6.72%
Ex-Dividend DateApr 27, 2026
Payout FrequencyQuarterly
Payout Ration/a
Volume461
Open25.06
Previous Close25.05
Day's Range25.06 - 25.09
52-Week Low24.76
52-Week High26.09
Betan/a
Holdings6
Inception DateJul 2, 2025

About FLXN

Fund Home Page

The Horizon Flexible Income ETF (FLXN) is an exchange-traded fund that mostly invests in high yield fixed income. The fund is actively managed, investing in high-yield fixed-income securities and adjusting exposures based on market and economic trends through income-producing assets, tactical credit shifts, and put spread overlays. This approach aims to deliver current income and pursue total return with risk-aware credit exposure. FLXN was launched on Jul 2, 2025 and is issued by Horizon.

Asset Class Fixed Income
Stock Exchange BATS
Ticker Symbol FLXN
ETF Provider Horizon

Dividend History

Ex-DividendAmountPay Date
Apr 27, 2026$0.68284Apr 28, 2026
Feb 27, 2026$0.11494Mar 2, 2026
Dec 24, 2025$0.73928Dec 26, 2025
Aug 22, 2025$0.14585Aug 25, 2025
Full Dividend History

Performance

News

Horizon Continues to Build Its Lineup of Exchange Traded Funds with the Launch of Two New Active Fixed Income ETFs

CHARLOTTE, N.C.--(BUSINESS WIRE)--Horizon launches Core Bond ETF (BNDY) and Flexible Income ETF (FLXN), expanding goals-based lineup, tools for advisors to meet client objectives.

Other symbols: BNDY
11 months ago - Business Wire

Pacira Biosciences to Snap Up Flexion Therapeutics; Shares Pop

New Jersey-based pharmaceutical company Pacira Biosciences, Inc. (PCRX) has signed an agreement to acquire biopharmaceutical firm Flexion Therapeutics, Inc. (FLXN) for $8.50 per share in cash and one ...

4 years ago - TipRanks